Skip to main content
Top

Journal of Cancer Research and Clinical Oncology

Issue 11/2025

Content (17 Articles)

Expression and therapeutic potential of TROP2 in cisplatin-resistant germ cell tumors

Laurenz Sperber, Melanie von Brandenstein, Carolina Kessler, Julian Heidenreich, Enno Storz, David Pfister, Pia Paffenholz, Yuri Tolkach, Marit Bernhardt, Ralph Wirtz, Markus Eckstein, Axel Heidenreich, Richard Weiten

Deficient DNA mismatch repair and Nectin-4 expression in upper tract urothelial carcinoma (UTUC)

Peichen Duan, Le Yu, Yichang Hao, Shaohui Deng, Peng Hong, Min Lu, Shudong Zhang

Prognostic impact of lymph node count features in total laryngectomy for advanced laryngeal squamous cell carcinoma

Mihnea Cristian Trache, Lisa Budelmann, Philippe Christophe Breda, Jördis Kristin Eden, Stefan Bartels, Sophia Marie Häußler, Christian Stephan Betz, Jacob Friedrich Clausen, Lukas Wittig, Arne Böttcher

From pathogenesis to the patient’s bedside: a comprehensive review of extraskeletal myxoid chondrosarcoma

Piotr Remiszewski, Sławomir Falkowski, Anna Szumera-Ciećkiewicz, Mateusz J. Spałek, Piotr Rutkowski, Anna M. Czarnecka

Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan

Wen-Kuan Huang, Po-Jung Su, Chun-Chi Chen, Ching-Fu Chang, Shao-Ming Yu, Ming-Jer Hsieh, Ming-Lung Tsai, Tien-Hsing Chen, Pao-Hsien Chu, I-Chang Hsieh, See-Tong Pang, Dong-Yi Chen

Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?

M. Talarico, S. Barbato, V. Maisnar, S. Delimpasi, M. Puppi, I. Rizzello, L. Pantani, P. Tacchetti, M. Martello, I. Vigliotta, C. Terragna, M. Cavo, Elena Zamagni, K. Mancuso

Comment on: Low expression of HSP27 and HSP70 predicts poor prognosis in laryngeal squamous cell carcinoma

Doga Topkan, Efsun Somay, Erkan Topkan, Ugur Selek

Correction: Comparison of TACE alone versus TACE combined with synchronous ablation for neuroendocrine neoplasms with liver metastases

Sun Huiyi, Wang Feihang, Yav Sothea, Zhao Danyang, Huo Zihao, Shuai Junqi, Yan Zhiping, Chen Yi, Liu Liang, Wang Wenquan, Ji Yuan, Liu Lingxiao

CAA-derived IL-6 promoted the PD-L1 expression of breast cancer via STAT3/miR-497a-5p signaling

Chongru Zhao, Xiaomei Zhou, Xing Li, Gezi Li, Qi Zhang, Jun Zhang

Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology

S. P. Mathibela, K. N. Ncube, M. T. Lebelo, V. Steenkamp

A cross-sectional analysis of the global burden of childhood leukemia from 1990 to 2021

Ping Wang, Jianing Cui, ZiHao Ni, Zhanhua Qian, Huili Zhan, Heng Zhang, Wei Ye, Wei Meng, Rongjie Bai

Keynote webinar | Spotlight on progress in colorectal cancer

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Prof. Antoni Castells
Prof. Harpreet Wasan
Prof. Edward Giovannucci
Watch now
Image Credits
Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images